BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 200349)

  • 21. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
    Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
    Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
    Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
    Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-elastin antibodies in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M
    Immunol Lett; 1992 Jul; 33(2):211-5. PubMed ID: 1332926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
    Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 26. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
    Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of immunoglobulin classes and subclasses to human neutrophils and eosinophils.
    Walsh GM; Kay AB
    Clin Exp Immunol; 1986 Feb; 63(2):466-72. PubMed ID: 3698341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum immunoglobulin levels and survival rates in bronchogenic carcinoma patients.
    Plesnicar S; Rudolf Z
    Neoplasma; 1979; 26(6):721-8. PubMed ID: 542209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment, prediagnosis immunoglobulin, and alpha 1-antitrypsin levels in patients with bronchial carcinoma.
    Nash DR; McLarty JW; Fortson NG
    J Natl Cancer Inst; 1980 Apr; 64(4):721-4. PubMed ID: 6966002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin content in the bronchial washings of patients with benign and malignant pulmonary disease.
    Mandel MA; Dvorak KJ; Worman LW; DeCosse JJ
    N Engl J Med; 1976 Sep; 295(13):694-8. PubMed ID: 958243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
    Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
    Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoglobulin levels in the serum and bronchial washings in patients with lung cancer].
    Pudelski J; Szczepański Z; Małecki S; Krzywiecki A; Cieślicki J; Wróbel-Lasok B
    Pneumonol Pol; 1982 Dec; 50(12):661-7. PubMed ID: 6304660
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
    Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
    Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary oat cell carcinomas. Expression of plasma membrane antigen correlated with presence of cytoplasmic neurosecretory granules.
    DeSchryver-Kecskemeti K; Kyriakos M; Bell CE; Seetharam S
    Lab Invest; 1979 Nov; 41(5):432-6. PubMed ID: 228116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Usefulness of antibodies against A60 mycobacterial antigen in tuberculosis diagnosis].
    Zielonka TM; Demkow U; Filewska M; Białas-Chromiec B; Boros P; Załeska J; Radzikowska E; Radziukiewicz-Byszewska D
    Pol Merkur Lekarski; 2002 Jun; 12(72):486-90. PubMed ID: 12362667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulins on the surface of monosodium urate crystals: an immunoelectron microscopic study.
    Bardin T; Varghese Cherian P; Schumacher HR
    J Rheumatol; 1984 Jun; 11(3):339-41. PubMed ID: 6737374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of membrane and cytoplasmic immunoglobulins in human leucocytes by immunoperoxidase staining.
    Mason DY; Labaume S; Preud'homme JL
    Clin Exp Immunol; 1977 Sep; 29(3):413-21. PubMed ID: 338219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.